{"id":26432,"date":"2012-05-18T21:16:39","date_gmt":"2012-05-19T01:46:39","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=26432"},"modified":"2012-05-18T23:51:02","modified_gmt":"2012-05-19T04:21:02","slug":"caso-no-202-mayo-15-2012-morfea-lineal","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/26432","title":{"rendered":"Caso N\u00ba 202, Mayo, 15, 2012: Morfea Lineal"},"content":{"rendered":"<p><em><strong>Dra Ayezel Mu\u00f1oz<br \/>Dra Belkis Noya<br \/>Dra Ana Maria Saenz<br \/>Dra Michelle de Arbeloa<br \/>Dr Francisco Gonzalez<br \/><\/strong><span style=\"font-size: x-small;\"><strong>Servicio de Dermatolog\u00eda Pedi\u00e1trica Hospital Universitario de Caracas<\/strong><\/span><\/em><\/p>\n<p><strong>Identificaci\u00f3n:<\/strong><br \/>Edad: 6 a\u00f1os.\u00a0Sexo: femenino.\u00a0Fototipo: III .Procedencia: Edo. Anzo\u00e1tegui. Venezuela.<\/p>\n<p><!--more--><\/p>\n<p><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2012\/05\/foto-caso-202.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-26433\" style=\"margin: 10px;\" title=\"foto-caso-202\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2012\/05\/foto-caso-202-386x480.jpg\" alt=\"\" width=\"386\" height=\"480\" srcset=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2012\/05\/foto-caso-202-386x480.jpg 386w, https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2012\/05\/foto-caso-202.jpg 580w\" sizes=\"auto, (max-width: 386px) 100vw, 386px\" \/><\/a><\/p>\n<p><strong>Resumen de caso:<\/strong><br \/>Preescolar femenina de 6 a\u00f1os de edad, quien presenta desde los 3 a\u00f1os de edad, placa atr\u00f3fica de base eritematosa localizada en hemicara derecha, que progresa en forma r\u00e1pida con desviaci\u00f3n de rasgos faciales y ausencia casi total de la grasa subyacente. Se realiza el diagn\u00f3stico de Morfea Lineal<br \/>Posterior a Dx (13\/10\/10) se inicia tratamiento con Prednisona (no precisa dosis) VO, Metotrexate: 10mg\/semanal VO, \u00c1cido F\u00f3lico 5 mg VO OD (los d\u00edas que no toma MTX), Calcipotriol unguento(Daivonex \u00ae).<br \/>Presenta mejor\u00eda progresiva con disminuci\u00f3n de la induraci\u00f3n local y desaparici\u00f3n del eritema.<\/p>\n<p>Antecedentes familiares: no contributorios.<\/p>\n<p>Antecedentes personales: Hemangioma en l\u00ednea media de cuello.<\/p>\n<p>Evoluci\u00f3n:<br \/>\u2022 22\/11\/10: Prednisona 10 mg por 1 mes, luego 10 mg intercalados con 5 mg diarios, hasta nueva cita. Metotrexate 10 mg semanal.<br \/>\u2022 09\/05\/11: Prednisona 10 mg intercalados con 5 mg diarios. Metotrexate 7,5 mg semanal.<br \/>\u2022 23\/09\/11: Prednisona se disminuye a 5 mg intercalados con 2,5 mg diarios. Metotrexate 10 mg semanal.<br \/>\u2022 09\/12\/11: Metotrexate 7,5mg semanal.<br \/>\u2022 03\/05\/11: Metotrexate 5mg semanal.<\/p>\n<p>1. \u00bfCu\u00e1l es su Diagn\u00f3stico?<br \/>2. \u00bfQu\u00e9 tratamiento aconsejar\u00eda?<br \/>3. \u00bfEstar\u00eda de Acuerdo en Utilizar sustancias de relleno?<\/p>\n<p><strong><br \/><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Preescolar femenina de 6 a\u00f1os de edad, quien presenta desde los 3 a\u00f1os de edad, placa atr\u00f3fica de base eritematosa localizada en hemicara derecha, que progresa en forma r\u00e1pida con desviaci\u00f3n de rasgos faciales y ausencia casi total de la grasa subyacente. Se realiza el diagn\u00f3stico de Morfea Lineal<\/p>\n","protected":false},"author":11,"featured_media":26433,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,20],"tags":[],"class_list":["post-26432","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-secciones-de-colaboradores","category-dermatologia-pediatrica"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/26432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=26432"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/26432\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media\/26433"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=26432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=26432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=26432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}